Detalhe da pesquisa
1.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
N Engl J Med
; 387(12): 1099-1110, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129998
2.
Lipocalin-2 is increased in amyotrophic lateral sclerosis.
Muscle Nerve
; 62(2): 272-283, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369618
3.
Altered White Matter Organization in the TUBB3 E410K Syndrome.
Cereb Cortex
; 29(8): 3561-3576, 2019 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30272120
4.
An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation.
Hum Mol Genet
; 21(26): 5484-99, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23001566
5.
A novel syndrome caused by the E410K amino acid substitution in the neuronal ß-tubulin isotype 3.
Brain
; 136(Pt 2): 522-35, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23378218
6.
Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS.
Amyotroph Lateral Scler Frontotemporal Degener
; : 1-11, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501453
7.
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Neurotherapeutics
; 19(4): 1248-1258, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585374
8.
Comparison of Two Clinical Upper Motor Neuron Burden Rating Scales in ALS Using Quantitative Brain Imaging.
ACS Chem Neurosci
; 12(5): 906-916, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576234
9.
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Amyotroph Lateral Scler Frontotemporal Degener
; 22(7-8): 467-477, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33771057
10.
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial.
Neuroimage Clin
; 30: 102672, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016561
11.
Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
J Nucl Med
; 61(11): 1621-1627, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32169920
12.
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis.
Front Neurol
; 10: 135, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30881332
13.
Neuronal-Specific TUBB3 Is Not Required for Normal Neuronal Function but Is Essential for Timely Axon Regeneration.
Cell Rep
; 24(7): 1865-1879.e9, 2018 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110642
14.
Susceptibility Etching on MRI in Patients with Microangiopathy.
J Neuroimaging
; 27(1): 43-49, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27539492
15.
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Neurotherapeutics
; 19(5): 1686, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175782
16.
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
J Clin Neurosci
; 23: 159-161, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412254
17.
Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome.
J Clin Endocrinol Metab
; 100(3): E473-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559402
18.
Preface: promoting research in PLS: current knowledge and future challenges.
Amyotroph Lateral Scler Frontotemporal Degener
; 21(sup1): 1-2, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602018
19.
Clinical Reasoning: An 82-year-old man with worsening gait.
Neurology
; 89(21): e246-e252, 2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158302
20.
Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
Muscle Nerve
; 39(3): 297-303, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208404